You are here

Treszl Andrea

Treszl Andrea

Treszl Andrea
Name: Treszl Andrea
Other profiles: MTMT
Profession: molecular biologist

Publication list

Uploaded publications:
30
Publications in DEA:
30
OA:
4
Date range:
2001-2017
2017
  1. Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
    Oncol. Rep. 37 1927-1934, 2017.
    Journal metrics:
    Q3 Cancer Research
    Q1 Medicine (miscellaneous)
    Q2 Oncology
2014
2013
  1. Treszl, A., Steiber, Z., Schally, A., Block, N., Dezső, B., Oláh, G., Rózsa, B., Molnár-Fodor, K., Buglyó, A., Gardi, J., Berta, A., Halmos, G.: Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.
    Oncotarget. 4 (10), 1721-1728, 2013.
    Journal metrics:
    D1 Oncology
  2. Seitz, S., Buchholz, S., Schally, A., Jayakumar, A., Weber, F., Papadia, A., Rick, F., Szalontay, L., Treszl, A., Köster, F., Ortmann, O., Hohla, F.: Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
    Anti-Cancer Drugs. 24 (2), 150-157, 2013.
    Journal metrics:
    Q3 Cancer Research
    Q2 Oncology
    Q2 Pharmacology
    Q2 Pharmacology (medical)
2011
  1. Szilasi, M., Buglyó, A., Treszl, A., Kiss, L., Schally, A., Halmos, G.: Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
    Int. J. Oncol. 39 (4), 1019-1024, 2011.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
  2. Papadia, A., Schally, A., Halmos, G., Varga, J., Seitz, S., Buchholz, S., Rick, F., Zarándi, M., Bellyei, S., Treszl, A., Szalontay, L., Lucci, I.: Growth Hormone-Releasing Hormone Antagonists Inhibit Growth of Human Ovarian Cancer.
    Horm. Metab. Res. 43 (11), 816-820, 2011.
    Journal metrics:
    Q2 Biochemistry
    Q1 Biochemistry (medical)
    Q2 Clinical Biochemistry
    Q2 Endocrinology
    Q2 Endocrinology, Diabetes and Metabolism
    Q1 Medicine (miscellaneous)
2010
  1. Barok, M., Balázs, M., Lázár, V., Rákosy, Z., Tóth, E., Treszl, A., Vereb, G., Colbern, G., Park, J., Szöllősi, J.: Characterization of a novel, trastuzumab resistant human breast cancer cell line.
    Front. Biosci. (Elite Ed). 1 (2), 627-640, 2010.
    Journal metrics:
    Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
    Q4 Immunology and Microbiology (miscellaneous)
    Q2 Medicine (miscellaneous)
2009
  1. Rózsa, B., Juhász, A., Treszl, A., Tóth, G., Flaskó, T., Dezső, B., Block, N., Schally, A., Halmos, G.: Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia.
    Int. J. Oncol. 35 (5), 1053-1059, 2009.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
  2. Ziegler, C., Brown, J., Schally, A., Erler, A., Gebauer, L., Treszl, A., Young, L., Fishman, L., Engel, J., Willenberg, H., Petersenn, S., Eisenhofer, G., Ehrhart-Bornstein, M., Bornstein, S.: Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues.
    Proc. Natl. Acad. Sci. U.S.A. 106 (37), 15879-15884, 2009.
    Journal metrics:
    D1 Multidisciplinary
  3. Márka, M., Semjéni, M., Treszl, A., Tóth, G., Flaskó, T., Dezső, B., Halmos, G.: Expression of somatostatin receptor subtypes in human bladder carcinoma.
    Acta Physiol. Hung. 96 (1), 100, 2009.
  4. Treszl, A., Schally, A., Seitz, S., Szalontay, L., Rick, F., Szepesházi, K., Halmos, G.: Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
    Peptides. 30 (9), 1643-1650, 2009.
    Journal metrics:
    Q2 Biochemistry
    Q4 Cellular and Molecular Neuroscience
    Q2 Endocrinology
    Q2 Physiology
  5. Seitz, S., Schally, A., Treszl, A., Papadia, A., Rick, F., Szalontay, L., Szepesházi, K., Ortmann, O., Halmos, G., Hohla, F., Buchholz, S.: Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
    Anticancer Drugs. 20 (7), 553-558, 2009.
    Journal metrics:
    Q2 Cancer Research
    Q2 Oncology
    Q2 Pharmacology
    Q1 Pharmacology (medical)
2008
  1. Papadia, A., Schally, A., Seitz, S., Buchholz, S., Treszl, A., Szalontay, L., Halmos, G., Lucci, I.: Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues.
    Gynecol. Oncol. 111 (2), 376, 2008.
  2. Seitz, S., Schally, A., Papadia, A., Ortmann, O., Buchholz, S., Treszl, A.: Inhibition of tumor growth of MDA-MB-231 human breast cancers by targeted cytotoxic analogue of somatostatin AN-162 (AEZS-124).
    Geburtshilfe Frauenheilkd. 68 S27, 2008.
  3. Szepesházi, K., Schally, A., Treszl, A., Seitz, S., Halmos, G.: Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Anticancer Drugs. 19 (4), 349-358, 2008.
    Journal metrics:
    Q2 Cancer Research
    Q2 Oncology
    Q2 Pharmacology
    Q1 Pharmacology (medical)
  4. Barok, M., Balázs, M., Nagy, P., Rákosy, Z., Treszl, A., Tóth, E., Juhász, I., Park, J., Isola, J., Vereb, G., Szöllősi, J.: Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.
    Cancer Lett. 260 (1-2), 198-208, 2008.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
2007
2006
  1. Treszl, A., Ladányi, A., Rákosy, Z., Buczkó, Z., Ádány, R., Balázs, M.: Molecular cytogenetic characterization of a novel cell line established from a superficial spreading melanoma.
    Front. Biosci. 11 (1), 1844-1853, 2006.
    Journal metrics:
    Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
    Q1 Immunology and Microbiology (miscellaneous)
    D1 Medicine (miscellaneous)
2005
  1. Toida, M., Balázs, M., Rákosy, Z., Kató, K., Yamazaki, Y., Matsui, T., Suwa, T., Hatakeyama, D., Makita, H., Mori, S., Yamashita, T., Shibata, T., Ádány, R., Treszl, A.: Analysis of Ameloblastomas by Comparative Genomic Hybridization and Fluorescence in situ Hybridization.
    Cancer Genet. Cytogenet. 159 (2), 99-104, 2005.
    Journal metrics:
    Q3 Cancer Research
    Q3 Genetics
    Q3 Molecular Biology
Show all
updated: 2024-03-03, 02:09

SCImago quartiles of
scientific journal articles

Number of scientific articles: 18
Q1/D1 3 (16.7%)
Q1 13 (72.2%)
Q2 3 (16.7%)
Q3 2 (11.1%)
-
OK

SCImago subject areas and categories

Biochemistry, Genetics and Molecular Biology (16)
Cancer Research (9)
Cell Biology (3)
Endocrinology (3)
Biochemistry (2)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (2)
Biophysics (1)
Clinical Biochemistry (1)
Genetics (1)
Molecular Biology (1)
Physiology (1)
Medicine (15)
Oncology (9)
Medicine (miscellaneous) (5)
Pathology and Forensic Medicine (3)
Pharmacology (medical) (3)
Histology (2)
Biochemistry (medical) (1)
Endocrinology, Diabetes and Metabolism (1)
Hematology (1)
Pharmacology, Toxicology and Pharmaceutics (3)
Pharmacology (3)
Immunology and Microbiology (2)
Immunology and Microbiology (miscellaneous) (2)
Multidisciplinary (1)
Multidisciplinary (1)
Neuroscience (1)
Cellular and Molecular Neuroscience (1)

Genre chart

Year chart

Language chart

Other co-authors

Schally, Andrew Victor
Show more
Schally, Andrew Victor
Brown, Jeremy William L.
Ehrhart-Bornstein, M.
Jayakumar, Arumugam R.